Eastern Bank Royalty Pharma PLC Transaction History

Eastern Bank

$5.08 Billion
Q2 2025

A detailed history of Eastern Bank transactions in Royalty Pharma PLC stock. As of the latest transaction made, Eastern Bank holds 25,287 shares of RPRX stock, worth $906,791. This represents 0.02% of its overall portfolio holdings.

Number of Shares

25,287

Previous 26,444 4.38%

Holding current value

$906,791

Previous $823,000 10.69%

% of portfolio

0.02%

Previous 0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	SELL	$30.85 - $36.14 $35,693 - $41,813	-1,157 Reduced 4.38%	25,287 $911,000
Q1 2025 May 08, 2025	SELL	$25.75 - $33.86 $743,428 - $977,572	-28,871 Reduced 52.19%	26,444 $823,000
Q4 2024 Jan 13, 2025	SELL	$24.28 - $28.39 $16,000 - $18,709	-659 Reduced 1.18%	55,315 $1.41 Million
Q3 2024 Oct 21, 2024	SELL	$25.63 - $29.27 $13,173 - $15,044	-514 Reduced 0.91%	55,974 $1.58 Million
Q2 2024 Jul 23, 2024	SELL	$26.26 - $29.9 $10,871 - $12,378	-414 Reduced 0.73%	56,488 $1.49 Million
Q1 2024 May 09, 2024	SELL	$27.46 - $31.33 $240,686 - $274,607	-8,765 Reduced 13.35%	56,902 $1.73 Million
Q4 2023 Jan 25, 2024	SELL	$26.21 - $29.22 $296,592 - $330,653	-11,316 Reduced 14.7%	65,667 $1.84 Million
Q3 2023 Oct 17, 2023	SELL	$26.26 - $31.38 $6.39 Million - $7.63 Million	-243,177 Reduced 75.95%	76,983 $2.09 Million
Q2 2023 Jul 19, 2023	BUY	$29.6 - $36.56 $18,440 - $22,776	623 Added 0.19%	320,160 $9.84 Million
Q1 2023 Apr 19, 2023	BUY	$32.77 - $39.4 $2.83 Million - $3.4 Million	86,238 Added 36.96%	319,537 $11.5 Million
Q4 2022 Jan 24, 2023	BUY	$39.17 - $44.04 $9.14 Million - $10.3 Million	233,299 New	233,299 $0

Others Institutions Holding RPRX

# of Institutions

497

Shares Held

306M

Call Options Held

1.99M

Put Options Held

384K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $15.7B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eastern Bank, based on Form 13F filings with the SEC.

News

Stay updated on Eastern Bank with notifications on news.

Account